NCT07351110 Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.
| NCT ID | NCT07351110 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-08-30 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-08-30 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our overarching goal is to adapt and test the PINPOINT intervention -PatIent Navigation for the Prevention of CervIcal CaNcer inTervention. We will test the PINPOINT intervention among patients with high-risk profiles for cervical cancer who do not meet the recommended screening for cervical cancer.
Eligibility Criteria
Inclusion Criteria: The following eligibility criteria will be used to determine inclusion into the study: 1. Using the American Cancer Society (ACS) screening recommendations, adults aged over the age of 25 will be eligible 2. Active UF Internal Medicine patient and has had an appointment in the last 2 months. 3. Assigned sex at birth is female 4. Have Obesity or Type 2 Diabetes 5. Not currently pregnant (self-report) 6. Have not given birth in the prior 12 weeks 7. No previous history of cervical cancer 8. No previous history of a hysterectomy 9. Have not undergone cancer screening in the past 3 years or more 10. Reside in the UFHCI Catchment Area (Alachua, Baker, Bradford, Citrus, Clay, Columbia, Dixie, Gadsden, Gilchrist, Hamilton, Jefferson, Lafayette, Lake, Leon, Levy, Madison, Marion, Putnam, Sumter, Suwannee, Taylor, UnioF1n, or Wakulla County). 11. Have a mobile phone or access to a mobile phone that can be used to receive messages, or a valid email address. 12. Are not currently scheduled to receive cervical cancer screening via clinician sampling (pap smear). Exclusion Criteria: * Previous history of cervical cancer * Total hysterectomy * Pregnant
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07351110 clinical trial?
This trial is open to female participants only, aged 25 Years or older, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07351110 currently recruiting?
Yes, NCT07351110 is actively recruiting participants. Contact the research team at rmkuu@ufl.edu for enrollment information.
Where is the NCT07351110 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT07351110 clinical trial?
NCT07351110 is sponsored by University of Florida. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.